Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wiesneth

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Transfusion Science|November 3, 1996
Combined CD34 positive plus CD2 negative selection for effective T-cell depletion as GvHD-prophylaxis in HLA-nonidentical blood progenitor cell transplantationM Wiesneth, T Schreiner, W Friedrich, et al.
Bone Marrow Transplantation|January 1, 1993
In vitro and in vivo depletion of T cellsR Arnold, D Bunjes, M Wiesneth, et al.
Vox Sanguinis|August 3, 2011
Safety and frequency of whole blood donations from elderly donorsM Müller-Steinhardt, T Müller-Kuller, C Weiss, et al.
Deutsche Medizinische Wochenschrift (1946)|January 8, 1988
[Bone marrow transplantation as therapy in chronic myeloid leukemia]T Schmeiser, R Arnold, M Wiesneth, et al.
Bone Marrow Transplantation|September 22, 1999
Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in childrenS Müller, A Schulz, U Reiss, et al.
Histology and Histopathology|June 10, 2005
Labeling of adult stem cells for in vivo-application in the human heartJ M I Wiehe, O Zimmermann, J Greiner, et al.
International Journal of Oncology|September 18, 2004
Opsonization with a trifunctional bispecific (alphaCD3 x alphaEpCAM) antibody results in efficient lysis in vitro and in vivo of EpCAM positive tumor cells by cytotoxic T lymphocytesM Schmitt, A Schmitt, P Reinhardt, et al.
Bone Marrow Transplantation|March 1, 1995
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMTB Hertenstein, W Hampl, D Bunjes, et al.
Transplantation|April 1, 1987
Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow graftsD Bunjes, W Heit, R Arnold, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1988
Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantationT Schmeiser, E Kurrle, R Arnold, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Transfusion Science|November 3, 1996
Combined CD34 positive plus CD2 negative selection for effective T-cell depletion as GvHD-prophylaxis in HLA-nonidentical blood progenitor cell transplantationM Wiesneth, T Schreiner, W Friedrich, et al.
Bone Marrow Transplantation|January 1, 1993
In vitro and in vivo depletion of T cellsR Arnold, D Bunjes, M Wiesneth, et al.
Vox Sanguinis|August 3, 2011
Safety and frequency of whole blood donations from elderly donorsM Müller-Steinhardt, T Müller-Kuller, C Weiss, et al.
Deutsche Medizinische Wochenschrift (1946)|January 8, 1988
[Bone marrow transplantation as therapy in chronic myeloid leukemia]T Schmeiser, R Arnold, M Wiesneth, et al.
Bone Marrow Transplantation|September 22, 1999
Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in childrenS Müller, A Schulz, U Reiss, et al.
Histology and Histopathology|June 10, 2005
Labeling of adult stem cells for in vivo-application in the human heartJ M I Wiehe, O Zimmermann, J Greiner, et al.
International Journal of Oncology|September 18, 2004
Opsonization with a trifunctional bispecific (alphaCD3 x alphaEpCAM) antibody results in efficient lysis in vitro and in vivo of EpCAM positive tumor cells by cytotoxic T lymphocytesM Schmitt, A Schmitt, P Reinhardt, et al.
Bone Marrow Transplantation|March 1, 1995
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMTB Hertenstein, W Hampl, D Bunjes, et al.
Transplantation|April 1, 1987
Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow graftsD Bunjes, W Heit, R Arnold, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1988
Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantationT Schmeiser, E Kurrle, R Arnold, et al.
Pageof 8